GuangYuYuan(SH:600771) Xin Lang Zheng Quan·2025-10-16 02:04Core Viewpoint - Guangyuyuan's stock price has shown a slight increase this year, with a notable rise in recent trading days, indicating potential investor interest and market activity [1][2]. Group 1: Stock Performance - As of October 16, Guangyuyuan's stock price increased by 2.04%, reaching 19.47 CNY per share, with a trading volume of 45.14 million CNY and a turnover rate of 0.48%, resulting in a total market capitalization of 9.53 billion CNY [1]. - Year-to-date, Guangyuyuan's stock price has risen by 3.23%, with a 2.26% increase over the last five trading days, but has seen a decline of 2.55% over the past 20 days and 3.80% over the last 60 days [2]. Group 2: Company Overview - Guangyuyuan, established on November 25, 1996, and listed on November 5, 1996, is located in Taiyuan, Shanxi Province, and specializes in the production and sale of traditional Chinese medicine, premium Chinese medicine, and health wines [2]. - The company's revenue composition includes 72.19% from traditional Chinese medicine, 24.20% from premium Chinese medicine, 3.55% from health wines, and 0.06% from other sources [2]. - Guangyuyuan operates within the pharmaceutical and biological industry, specifically in the traditional Chinese medicine sector, and is associated with concepts such as new retail, pharmaceutical e-commerce, and Alzheimer's [2]. Group 3: Financial Performance - For the first half of 2025, Guangyuyuan reported a revenue of 779 million CNY, reflecting a year-on-year growth of 18.14%, while the net profit attributable to shareholders was 76.86 million CNY, marking a 28.95% increase [2]. - The company has cumulatively distributed 12.71 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 4: Shareholder Information - As of June 30, 2025, Guangyuyuan had 63,500 shareholders, a decrease of 5.12% from the previous period, with an average of 7,708 circulating shares per shareholder, which is an increase of 5.40% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest shareholder with 5.62 million shares, while Southern CSI 1000 ETF and Huaxia CSI 1000 ETF have increased their holdings [3].